Replies to post #16717 on Endonovo Therapeutics Inc (ENDV)

[Tkmoney1]

While I can understand the frustration, what can the company possibly do at this point? All the top officers have deferred their pay, the CEO has been buying on the open market now for over 8 months, and they have launched 4 pre-clinical trials. These trials cost money and so does operating the company. Everyone including those at ENDV want to release positive pre clinical trial data, as it will definitely help raise market cap. People that are complaining don't understand or refuse to understand what they are investing in. A novelty therapy that is in it's infancy with no data as of yet. So unless we get another pump like the last one or some data, this is how things will go.